Roche’s Experimental Obesity Drug Shows Powerful Weight Loss in Phase II Trial
Roche has reported strong Phase II clinical results for its experimental obesity medicine CT-388, raising optimism about the future…
Roche has reported strong Phase II clinical results for its experimental obesity medicine CT-388, raising optimism about the future…